Aging & Longevity

P2X7R deficiency alleviates cardiac senescence by enhancing mitophagy via the HuR/TRIM26/NR4A1 axis.

TL;DR

P2X7R deficiency alleviates cardiac senescence by enhancing mitophagy via the HuR/TRIM26/NR4A1 axis, whereby P2X7R promotes HuR nucleocytoplasmic shuttling to increase TRIM26 mRNA stability, leading to NR4A1 ubiquitination and proteasomal degradation that suppresses mitophagy and accelerates cardiac ageing.

Key Findings

Serum levels of P2X7R increase with advancing age in humans and P2X7R expression is upregulated during cardiac senescence in mice.

  • P2X7R expression was assessed in human serum samples across different age groups
  • P2X7R upregulation was observed in mouse cardiac tissue during senescence
  • Two mouse ageing models were used: natural ageing (20-month-old mice) and chronic subcutaneous D-galactose (D-gal) injection

P2X7R deficiency alleviates ageing-related cardiac dysfunction, senescence phenotypes, and impaired mitophagy.

  • P2X7R knockout (P2X7R-/-) mice were used to assess the role of P2X7R in cardiac ageing
  • Cardiac function and histopathological changes in cardiac tissues were evaluated in P2X7R-/- mice
  • P2X7R deficiency reduced senescence phenotypes and improved mitophagy in ageing hearts
  • Both natural ageing (20-month) and D-gal-induced ageing models were used to confirm findings

Cardiomyocyte-specific overexpression of P2X7R exacerbates myocardial dysfunction, senescence phenotype, and mitophagy disruption induced by D-galactose.

  • Recombinant adeno-associated virus serotype 9 (AAV9) was employed to achieve cardiac-specific overexpression of P2X7R
  • P2X7R overexpression worsened D-gal-induced myocardial dysfunction
  • P2X7R overexpression increased senescence phenotypes and disrupted mitophagy in cardiomyocytes
  • Findings confirm a gain-of-function role for P2X7R in cardiac ageing

P2X7R promotes HuR nucleocytoplasmic shuttling in ageing hearts, thereby increasing the mRNA stability of TRIM26 and expression of the E3 ubiquitin ligase TRIM26.

  • Transcriptome sequencing was applied to elucidate the potential mechanisms of P2X7R in cardiac senescence
  • P2X7R activation facilitated the shuttling of human antigen R (HuR) from nucleus to cytoplasm
  • HuR binding to TRIM26 mRNA increased its stability and thus TRIM26 protein expression
  • TRIM26 is identified as an E3 ubiquitin ligase in this signalling pathway

TRIM26 mediates NR4A1 ubiquitination and proteasomal degradation, which suppresses mitophagy in cardiomyocytes and accelerates cardiac ageing.

  • TRIM26 was identified as the E3 ubiquitin ligase responsible for NR4A1 ubiquitination
  • NR4A1 (nuclear receptor subfamily 4 group A member 1) undergoes proteasomal degradation following TRIM26-mediated ubiquitination
  • NR4A1 degradation suppresses mitophagy in cardiomyocytes
  • AAV9-mediated cardiac-specific overexpression of NR4A1 was used to validate its role in the pathway
  • The complete axis identified is HuR/TRIM26/NR4A1 as the key signalling pathway through which P2X7R regulates cardiac ageing

Have a question about this study?

Citation

Zhou Y, Zhong X, Mao Z, Chen Y, Xing J, Shen J, et al.. (2026). P2X7R deficiency alleviates cardiac senescence by enhancing mitophagy via the HuR/TRIM26/NR4A1 axis.. Clinical and translational medicine. https://doi.org/10.1002/ctm2.70621